PTC Therapeutics (PTCT) Misses Q3 EPS by 3c

PTC Therapeutics (NASDAQ: PTCT) reported Q3 EPS of ($0.93), $0.03 worse than the analyst estimate of ($0.90). Revenue for the quarter came in at $1.69 million versus the consensus estimate of $1.76 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Goldman Sachs on Titan Company (TTAN:IN): 'Lower gold prices could also create earnings tailwinds'
• TSMC targets 2029 for panel-level CoPoS packaging in AI chip push - DigiTimes